[{"arm_notes": "", "treatment_id": null, "treatment_name": "0.1 ml mRNA vaccine intradermal injection. Antibody levels are followed at 2-4 week and 12+/- weeks. Adverse event is followed for 7 days after injection ;0.3-0.5 ml mRNA vaccine intramuscular injection. Antibody levels are followed at 2-4 week and 12+/- weeks. Adverse event is followed for 7 days after injection.;Experimental Biological/Vaccine;Active Comparator Biological/Vaccine;intradermal;intramuscular", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "0.1 ml mRNA vaccine intradermal injection", "treatment_id": 1153, "treatment_name": "Sars-cov-2 mrna vaccine", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "0.3-0.5 ml mRNA vaccine intramuscular injection", "treatment_id": 1153, "treatment_name": "Sars-cov-2 mrna vaccine", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]